No Data
No Data
Wells Fargo Maintains Agilent Technologies(A.US) With Buy Rating, Cuts Target Price to $135
Agilent Is Maintained at Overweight by Wells Fargo
Agilent Technologies Gets European Certification For PD-L1 IHC 22C3 PharmDx To Help Gastric Or GEJ Adenocarcinoma Patients for KEYTRUDA Therapy
Express News | Agilent Technologies Inc - Receives European Ivdr Certification for Pd-L1 Ihc 22C3 Pharmdx
Express News | Agilent Technologies, Inc. : Wells Fargo Cuts Target Price to $135 From $155
Press Release: Agilent to Announce Second-Quarter Fiscal Year 2025 Financial Results on May 28